A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer

The EGFR R521K polymorphism has been shown to reduce the activity of EGFR; however, the association between EGFR R521K polymorphism and the risk of cancer remains inconclusive; therefore we performed a meta-analysis to evaluate the relationship between EGFR R521K polymorphism and susceptibility to c...

Full description

Saved in:
Bibliographic Details
Main Authors: Yinsheng Wang, Lidan Zha, Dan Liao, Xiaozhi Li
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2014/312102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552997669830656
author Yinsheng Wang
Lidan Zha
Dan Liao
Xiaozhi Li
author_facet Yinsheng Wang
Lidan Zha
Dan Liao
Xiaozhi Li
author_sort Yinsheng Wang
collection DOAJ
description The EGFR R521K polymorphism has been shown to reduce the activity of EGFR; however, the association between EGFR R521K polymorphism and the risk of cancer remains inconclusive; therefore we performed a meta-analysis to evaluate the relationship between EGFR R521K polymorphism and susceptibility to cancer. Our results suggest that the EGFR R521K polymorphism is not associated with risk of cancer, but the different chemosensitivity to anticancer drugs may need further investigation.
format Article
id doaj-art-9c0981197bf146efaa8d515a94265c39
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-9c0981197bf146efaa8d515a94265c392025-02-03T05:57:12ZengWileyInternational Journal of Genomics2314-436X2314-43782014-01-01201410.1155/2014/312102312102A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of CancerYinsheng Wang0Lidan Zha1Dan Liao2Xiaozhi Li3Department of Stomatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, No. 1 Yixueyuan Road, Chongqing 400016, ChinaDepartment of Stomatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, No. 1 Yixueyuan Road, Chongqing 400016, ChinaDepartment of Stomatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, No. 1 Yixueyuan Road, Chongqing 400016, ChinaDepartment of Stomatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, No. 1 Yixueyuan Road, Chongqing 400016, ChinaThe EGFR R521K polymorphism has been shown to reduce the activity of EGFR; however, the association between EGFR R521K polymorphism and the risk of cancer remains inconclusive; therefore we performed a meta-analysis to evaluate the relationship between EGFR R521K polymorphism and susceptibility to cancer. Our results suggest that the EGFR R521K polymorphism is not associated with risk of cancer, but the different chemosensitivity to anticancer drugs may need further investigation.http://dx.doi.org/10.1155/2014/312102
spellingShingle Yinsheng Wang
Lidan Zha
Dan Liao
Xiaozhi Li
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
International Journal of Genomics
title A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
title_full A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
title_fullStr A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
title_full_unstemmed A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
title_short A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
title_sort meta analysis on the relations between egfr r521k polymorphism and risk of cancer
url http://dx.doi.org/10.1155/2014/312102
work_keys_str_mv AT yinshengwang ametaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT lidanzha ametaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT danliao ametaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT xiaozhili ametaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT yinshengwang metaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT lidanzha metaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT danliao metaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer
AT xiaozhili metaanalysisontherelationsbetweenegfrr521kpolymorphismandriskofcancer